GRAIL Advances the Galleri® Registrational Clinical Trial Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. ALAR
3. SPY
4. PBA
5. CCH:LN
6. META
7. CCHGY
8. PRY:IM
9. PRYMY
10. SKA-B

Go back to GRAIL Advances the Galleri® Registrational Clinical Trial Program
(NASDAQ: GRAL) Delayed: 69.11 +1.00 (1.47%)
Previous Close $68.11    52 Week High $ 
Open $68.99    52 Week Low $ 
Day High $71.41    P/E N/A 
Day Low $67.63    EPS $ 
Volume 337,915